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Stationary-phase production of the antibiotic
actinorhodin in Streptomyces coelicolor A3(2) is
transcriptionally regulated
Hugo C. Gramajo, Eriko Takano and Mervyn J. Bibb*
John Innes Institute, John Innes Centre, Colney Lane,
Norwich NR4 7UH, UK.
Summary
Production of actinorhodin, a polyketide antibiotic
made by Streptomyces coelicolor A3(2), normally
occurs only in stationary-phase cultures. 51 nucle-
ase protection experiments showed that transcription
of actII-ORF4, the activator gene required for expres-
sion of the biosynthetic structural genes, increased
dramatically during the transition from exponential to
stationary phase. The increase in actII-ORF4 expres-
sion was followed by transcription of the biosynthetic
structural genes actIII and actVI-ORF1, and by the
production of actinorhodin. The presence of actII-
ORF4 on a multicopy plasmid resulted in enhanced
levels of actII-ORF4 mRNA, and transcription of actIII
and actinorhodin production during exponential
growth, suggesting that actinorhodin synthesis in
rapidly growing cultures is normally limited only by
the availability of enough of the activator protein.
bldA, which encodes a tRNALUeuUA that is required for
the efficient translation of a single UUA codon in the
actII-ORF4 mRNA, was transcribed throughout
growth. Moreover, translational fusions of the 5' end
of actII-ORF4 that included the UUA codon to the
ermE reporter gene demonstrated the presence of
functional bldA tRNA in young, exponentially grow-
ing cultures and no increase in the efficiency of trans-
lation of UUA codons, relative to UUG codons, was
observed during growth. The normal growth-phase-
dependent production of actinorhodin in the liquid
culture conditions used in these experiments
appears to be mediated at the transcriptional level
through activation of the actII-ORF4 promoter.
Introduction
Antibiotic production in the Gram-positive prokaryotic
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genus Streptomyces generally occurs in the stationary
phase in liquid medium, and correlates temporally with
the onset of morphological differentiation in surface-
grown cultures (Demain et al., 1983; Chater, 1989). Much
progress has been made in elucidating the organization
of antibiotic biosynthetic gene clusters in several different
Streptomyces species (Hunter and Baumberg, 1989),
and a number of pathway-specific regulatory genes have
been identified that are required for the activation of their
cognate biosynthetic structural genes (Distler et al., 1987;
Narva and Feitelson, 1990; Fernandez-Moreno et al.,
1991; Raibaud et al., 1991; Stutzman-Engwall et al.,
1992; Geistlich et al., 1992). However, little is understood
of the regulatory mechanisms that are involved in the
expression of the activator genes.
In Streptomyces coeticolor A3(2), the most fully geneti-
cally characterized streptomycete, potential pleiotropic
regulatory genes have been identified that are required
for, or influence, the production of all four of the antibiotics
(actinorhodin, undecylprodigiosin, methylenomycin, and
a calcium-dependent antibiotic; Hopwood, 1988) known
to be made by this strain. These genes fall into two
classes: those that affect only antibiotic production (absA
(Adamidis et al., 1990) and absB (Champness et al.,
1990), afsB (Horinouchi et al., 1983; Horinouchi et al.,
1989), afsR (Horinouchi et al., 1990) and abaA (Fernan-
dez-Moreno et al., 1992)), and those that affect both
antibiotic production and morphological differentiation
(bldA-D and bldG-H; Hopwood, 1988; Champness,
1988; Chater, 1989). The existence of these bId mutants
suggests that morphological differentiation and antibiotic
production share some elements of genetic control. Of
particular note is bldA; this gene encodes a tRNALUeuUAthat
is apparently the only tRNA species in S. coeticolor A3(2)
that can efficiently translate the rare leucine codon UUA
(Leskiw et al., 1991 b). Moreover, the majority (12/15) of
UUA codons so far identified in streptomycetes are found
in genes connected with antibiotic production or morpho-
logical differentiation that are expected to be expressed
late in growth (Leskiw et al., 1991 a). In particular, actII-
ORF4, the pathway-specific activator gene for acti-
norhodin biosynthesis, encodes an mRNA that contains a
single UUA codon whose replacement by UUG led to a
loss of bldA-dependence of actinorhodin production,
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Fig. 1. A. Growth curve of S. coelicolor A3(2) strain M145 in casamino-acid-supplemented medium; to, doubling time (h); the shaded box labelled ACT indi-
cates the presence of actinorhodin in the culture.
B, C and D. S1 nuclease mapping of actII-ORF4 (B), actIII (C), and actVI-ORF1 (D) transcripts in RNA samples obtained from the culture shown in (A) at
the times indicated; EXP and STAT, exponential and stationary phases of growth, respectively; the shaded area between them indicates the transition
phase; SM, end-labelled HpaII-digested pBR322 size marker; Probe, the location of full-length probe. The lower band present in (D) may represent a sec-
ond transcriptional start site for actVI-ORF1, RNA processing or degradation, or an artefact of the S1 nuclease mapping procedure.
prompting suggestions that this codon was the direct tar-
get for translational control of actinorhodin production by
bldA (Fernandez-Moreno et al., 1991).
Here, we assess the temporal and growth-phase-
dependent expression of actII-ORF4, the actinorhodin
biosynthetic structural genes actIII (Hallam et al., 1988)
and actVI-ORF1 (F. Malpartida, personal communica-
tion), and bldA, and provide evidence to suggest that bldA
is not involved, under the conditions used, in the temporal
regulation of actinorhodin production, which appears to
occur at the transcriptional level.
Results
Actinorhodin gene expression is growth-phase-
dependent
S. coelicolor A3(2) strain M145 grew in casamino-acid-
supplemented minimal medium with a doubling time of
2.1 h and began the transition into stationary phase
approximately 15 h after inoculation, whereupon acti-
norhodin appeared in the mycelium (Fig. 1A). S1 nucle-
ase protection experiments with RNA from expo-
nential and stationary phase cultures revealed actII-
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ORF4 transcripts at a low level in exponential phase; their
amount increased greatly at the end of exponential
growth (Fig. 1B), with the highest levels occurring during
the transition phase (the increase in the level of fully pro-
tected probe, which follows the increase in the level of the
actII-ORF4 transcript, was not always observed, but may
reflect transcriptional readthrough from actII-ORF3 (Fer-
nlndez-Moreno et al., 1991 )). Transcripts for actIII and
actVI-ORF1 were detected 13.3 hand 14.3 h after inocu-
lation, respectively (Fig. 1, C and D), and increased in
abundance as the culture entered stationary phase, fol-
lowing closely the increase in the level of actII-ORF4
mRNA.
The effect of extra copies of actII-ORF4 on the tempo-
ral expression of actIII and on actinorhodin production
was assessed in M145 containing multicopy plasmid
p1J68. actII-ORF4 transcripts were readily detected in
early exponential cultures and their level increased
markedly in mid-exponential phase and then remained
constant (Fig. 2A). A similar, but slightly delayed profile,
was observed for the actIII transcripts (Fig. 2B) (a faint
band was also observed in the earliest sample (OD450nm
= 0.28) after prolonged exposure). Actinorhodin produc-
tion was first detected spectrophotometrically during mid
to late exponential growth; the concentration in station-
ary-phase cultures was approximately 10 times that
observed with M145.
Transcription of bid A occurs throughout growth in liquid
culture
S1 nuclease protection experiments were performed with
RNA from exponential- and stationary-phase cultures to
assess the temporal pattern of bldA transcription (Fig. 3).
The smallest protected fragment (approximately 80
nucleotides (nt) represents the 5' end of the mature
tRNAULeuUA(Lawlor et al., 1987); the other two bands were
observed also either in in vitro transcription studies (the
band of approximately 150 nt; (Lawlor, 1987) or some-
times in primer extension experiments (the band of
approximately 100 nt; B. K. Leskiw, personal communica-
tion), and both may represent in vivo transcriptional start
sites. Whereas the levels of the larger protected frag-
ments declined with culture age (after an initial increase in
the c. 100 nt fragment), the fragment representing the 5'
end of the mature tRNAULeuUAincreased slightly during early
exponential growth and then remained relatively con-
stant. An essentially identical profile of bldA transcripts
was observed using a richer medium (YEME; Hopwood et
al., 1985) and spores of S. coelicolor A3(2) M145 that had
not been germinated prior to inoculation, suggesting that
the profiles are typical of cultures grown in liquid medium.
To confirm that the signals observed represented bldA,
and not cross-hybridization to related tRNA species, S 1
nuclease protection experiments were carried out on
RNA isolated from early and late exponential phase, and
stationary-phase cultures of S. coelicolor A3(2) strains
J1501 (bldA+) and J1681 (ΔbldA); prolonged exposure
revealed a faint signal with RNA from J1681, but a very
strong one with RNA from J1501 (Fig. 3; only the results
obtained with the stationary-phase cultures are shown),
indicating that almost all of the signal observed in M145
represented bldA transcripts.
Translation of UUA codons in an actII-ORF4::ermE
fusion transcript occurs throughout growth in liquid
culture
The presence of bldA transcripts throughout growth did
not necessarily reflect the presence of a functional bldA
tRNAULeuUA;perhaps the lack of 3' processing, charging by
the appropriate amino acyl tRNA synthetase, or some
Fig. 2. A, B. S1 nuclease mapping of actII-ORF4
(A) and actIII (B) transcripts in RNA samples
obtained from M 145(pIJ68) cultures at the optical
densities indicated. See the legend to Fig. 1 for
other abbreviations.
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Fig. 3. S1 nuclease mapping of bldA transcripts in RNA samples pre-
pared from S. coelicolor A3(2) strains M145, J1501 and J1681 (ΔbldA).
tRNA, protected fragment corresponding to the 5' end of the mature bldA
tRNA; S1 PE and S1 IVT, S1-nuclease-resistant fragments correspond-
ing to the 5' end of transcripts observed previously in primer extension
experiments or in in vitr o transcription studies, respectively. See the leg-
end to Fig. 1 for other abbreviations.
other modification, prevented translation of UUA codons
during exponential growth. To address this point, transla-
tional fusions were made between the 5' region of actII-
ORF4, including the actII-ORF4 promoter and the unique
UUA codon, and the ermE gene of Saccharopolyspora
erythrea. ermE, which confers resistance to macrolide,
lincosamide and streptogramin B-type antibiotics,
encodes a 23S rRNA methylase (Uchiyama and Weis-
blum, 1985; Dhillon and Leadlay, 1990) for which poly-
clonal antibodies had been raised using oligopeptides as
antigens. pIJ2250 contained the first five codons of actII-
ORF4, with the fifth being the unique UUA codon;
pIJ2251 differed in that the UUA codon had been
changed to the synonymous leucine codon UUG, and
pIJ2252 differed from pIJ2250 in containing additional
UUA codons at positions six and seven (Fig. 4). Protein
and RNA samples were prepared from cultures contain-
ing the three plasm ids during exponential growth and dur-
ing the transition into stationary phase, and analysed by
Western blotting and S1 nuclease mapping. The ermE
methylase (with a predicted size of 43 kDa (EMBL
nucleotide database accession number X51891), but
which migrates on SDS-polyacrylamide gels against pre-
stained markers with an apparent size of 45 kDa; M. J.
Bibb, unpublished) was readily detected in extracts from a
control culture, M145(pIJ427) (a pIJ486 derivative that
contains the native ermE), but not in extracts from
M145(pIJ486) (a negative control). The three construc-
tions containing the translational fusions were expected
to give a novel protein of 44.3 kDa; all three yielded a
fusion protein larger than the native methylase. Moreover,
the fusion protein was readily detected in early exponen-
tial growth and increased in amount as the culture
entered the transition phase. While the amounts of fusion
protein detected in extracts of M145 containing pIJ2250
or pIJ2251 were very similar, the level obtained from
pIJ2252 was higher. To assess whether this difference,
and the temporal increase in the level of the fusion pro-
teins, reflected an increase in translational efficiency or
an increase in the amount of transcript, RNA from culture
samples corresponding in time to those used for protein
extraction were monitored by S1 nuclease mapping
(Fig. 5B). The fusion protein:fusion transcript ratio
increased during growth approximately twofold for all
three cultures. The level of fusion mRNA observed with
p1J2252, which contains three UUA codons, was notably
higher than with the other two constructions (Fig. 5B).
Translation of actII-ORF4::ermE fusion transcripts
containing UUA codons is bldA-dependent
The presence of actII-ORF4 on a multicopy plasmid
restores actinorhodin production to bldA mutants (Pas-
santino et al., 1991), presumably by a low level of mis-
translation of the unique UUA codon by another tRNA via
an imperfectly matched codon-anticodon interaction;
increased levels of actII-ORF4 transcripts from the multi-
copy vector presumably allow for the synthesis of enough
Fig. 4. The nucleotide and predicted amino acid
sequences in the actII-ORF4::er mE fusions in
pIJ2250-pIJ2252. Shaded triplets indicate the
actII-ORF4 UUA codon in pIJ2250, and changes
from the sequence present in the latter in pIJ2251
and p1J2252. The ATG triplet corresponding to
the translational start codon of actII-ORF4 and of
the fusion transcripts is underlined; the GTG cor-
responding to the translational start codon of
er mE is in italics and the BamHI site used for
cloning is in bold letters.
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Fig. 5. A. Western analysis of cell extracts of S. coelicolor A3(2) strain M145 derivatives containing pIJ2250, pIJ2251, and pIJ2252, using antibodies
against the ermE methylase. Cell extracts from M145 containing pIJ427 and pIJ486 were used as positive and negative controls, respectively; SM, size
markers.
B. S1 nuclease mapping of actII-ORF4::ermEtranscripts in RNA samples from the same cultures used in A. The asterisk indicates the protected fragment
that results from cleavage by S1 nuclease at the region of mismatch between the probe (obtained by PCR using pIJ2250 as a template) and the fusion tran-
scripts. The faint bands present at a similar position in the pIJ2250 and pIJ2251 tracks do not comigrate with this protected fragment upon prolonged elec-
trophoresis and are present in all lanes; they may reflect an artefact of the S1 nuclease mapping procedure. See the legend to Fig. 1 for other abbreviations.
activator to elicit expression of the act structural genes.
The same explanation might have applied to the results
obtained with the actII-ORF4::ermE fusions, since they
are also present on a high-copy-number plasmid. To
assess whether the fusion protein detected by Western
blotting in young cultures resulted from translation of the
UUA codons by tRNAULeuUA,and not by mis-translation, the
three plasmids were introduced into the S. coelicolor
A3(2) bldA mutant J1700, and the amount of fusion pro-
tein and fusion mRNA in exponential cultures was anal-
ysed. The fusion protein was detected only in extracts
prepared from J1700(pIJ2251) (Fig. 6A), although the
levels of fusion transcript detected in J1700(p1J2250) and
J1700(p1J2251) were very similar (Fig. 6B). As noted for
M145, the level of fusion mRNA with pIJ2252 was higher
than with the other two constructions (Fig. 6B).
Discussion
Transcription of the activator gene actII-ORF4 is clearly
growth-phase-dependent in liquid medium, reaching a
maximum during the transition from exponential to sta-
tionary phase. Transcription of actIII and actVI-ORF1
occurs after the accumulation of almost maximal levels of
the actII-ORF4 transcript, suggesting that a threshold
concentration of the activator is needed for transcription
of the biosynthetic structural genes, a possibility noted by
Hopwood et al. (1986). The presence of multiple copies of
actII-ORF4 leads to high levels of the actII-ORF4 tran-
script; probably as a consequence, expression of actIII is
enhanced and actinorhodin appears in early to mid-expo-
nential growth, suggesting that the only limitation on acti-
norhodin production in rapidly growing cultures, under the
Fig. 6. A. Western analysis of cell extracts of S. coelicolor A3(2) strain J1700 derivatives containing pIJ2250, pIJ2251 and pIJ2252, using antibodies
against the ermE methylase. Cell extracts from J1700 containing pIJ427 and pIJ486 were used as positive and negative controls, respectively; SM, size
markers.
B. S1 nuclease mapping of actII-ORF4::ermEtranscripts in RNA samples from the same cultures used in (A). Probe, the location of full-length probe. See
the legend to Fig. 5B for other abbreviations
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conditions used, is the availability of enough of the activa-
tor. Although the elevated levels of the actII-ORF4 tran-
script obtained with pIJ68 might reflect titration of a puta-
tive actII-ORF4 repressor, there is no genetic evidence to
suggest the existence of a negatively acting regulatory
gene. The reason for the increase in the level of the actII-
ORF4 mRNA, and presumably therefore the actIII tran-
script, during early exponential growth of M145(pIJ68)
(Fig. 2) and the continual rise in the level of the fusion
transcripts throughout exponential growth (Figs. 5B and
6B) is not known, but may reflect increases in copy num-
ber of pIJ101 derivatives such as pIJ486 during rapid
growth (H. Richards, personal communication). Consider-
ably higher levels of actII-ORF4::ermE mRNA were
observed for p1J2252, relative to pIJ2250 and p1J2251, in
both M145 and J1700. This may reflect a more stable
transcript, but why this should result from the presence of
three consecutive UUA codons is obscure; sequence
analysis failed to reveal any potential secondary structure
in this region of the fusion transcripts that might have
influenced mRNA stability.
The pleiotropic effect of bldA mutations on antibiotic
production, the unusual distribution of UUA codons and
data suggesting that bldA, in surface-grown cultures, was
transcribed only later in growth (Lawlor et al., 1987), led to
the proposal that bldA represented a novel mechanism of
translational control of antibiotic production (Chater,
1990; Leskiw et al., 1991 b). This was consistent with data
indicating that the transcription of undecylprodigiosin
(Guthrie and Chater, 1990), actinorhodin (Bruton et al.,
1991; Fernandez-Moreno et al., 1991) and methyleno-
mycin (A. Wietzorrek and K. F. Chater, personal commu-
nication) biosynthetic structural genes was greatly
reduced in bldA mutants. In the conditions we generally
use, which were developed to analyse the growth-phase-
dependent expression of antibiotic biosynthetic genes in
liquid culture, abundant amounts of a transcript corre-
sponding to the 5' end of the mature bldA tRNA were
detected in young, exponentially growing cultures
(Fig. 3). Since essentially identical results were obtained
using richer medium and spores that had not been germi-
nated prior to inoculation, the early transcription of bldA
may be a common feature of cultures grown in liquid
medium. Moreover, the tRNAULeuUAwas functional since it
could translate the UUA codons present in the actII-
ORF4::ermE fusion transcripts in equally young cultures,
and there was no apparent increase in the relative effi-
ciency of translation of UUA codons, relative to UUG
codons, during growth. The possibility of significant levels
of mis-translation of the UUA codons in the fusion mRNAs
was ruled out by the virtual absence of the fusion protein
in the bldA mutant J1700 containing either pIJ2250 or
pIJ2252 (the low level of fusion protein detected at the
last time point for the later construct (Fig. 6A) may reflect
a low level of mis-translation of the relatively abundant
transcript). These observations suggest that bldA does
not playa role in the temporal regulation of actII-ORF4
expression and actinorhodin production in the culture
conditions used here.
In contrast to the results reported here, B. Leskiw and
co-workers (personal communication) have obtained data
that are consistent with the temporal activation of bldA; at
present we have no explanation for the disparity between
the two sets of results. Although we have not replaced the
UUA codon of the chromosomal actII-ORF4 with a syn-
onymous leucine codon and assessed the effect on the
timing of actinorhodin production, the low level of actII-
ORF4 transcription during exponential phase, and the
lack of any detectable difference in the apparent effi-
ciency of translation of UUA and UUG codons throughout
growth, strongly suggest that such a change would have
no effect.
The incidence of UUA codons in Streptomyces genes
remains intriguing. With a few exceptions (for which pos-
sible explanations have been proposed), UUA codons are
found only in genes that one would expect to be
expressed only late in the growth of the organism (Leskiw
et al., 1991 b), consistent with a potential regulatory role
for the codons. But if UUA codons are not regulatory tar-
gets for bldA, how can their incidence be explained? Pre-
sumably, during evolution, streptomycetes have been
subjected to a mutational bias that has led to a high
genomic G+C content (on average, 74 mol%; Gladek and
Zakrzewska, 1984) and consequently to a high degree of
synonymous codon preference in which G+C-rich codons
predominate (Wright and Bibb, 1992). In addition to muta-
tional bias, there is evidence for translational selection in
Streptomyces (Wright and Bibb, 1992); if UUA codons
were inefficiently translated, they might have been selec-
tively removed from genes expressed at high and moder-
ate levels, but retained in those expressed at low levels.
Regulatory genes, like actII-ORF4, are generally
expected to be expressed at low levels. The occurrence
of UUA codons in such genes, and not in the primary
metabolic and antibiotic biosynthetic structural genes
sequenced so far, may reflect the operation of transla-
tional selection in the latter, rather than a novel mecha-
nism of translational control. However, the levels of fusion
proteins observed in these studies (Fig. 5) would suggest
that UUA is translated at least as efficiently as UUG. Fur-
thermore, the correspondence between the amount of
fusion transcript and protein observed with M145/p1J2251
and M145/p1J2252 suggests that the presence of UUA
codons is not a rate-limiting factor during translation.
Thus, in the absence of a confirmed regulatory role for
bldA, a satisfactory explanation for the unusual occur-
rence of UUA codons remains elusive.
From these studies we conclude that the growh-phase-
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dependent regulation of actinorhodin biosynthesis, under
the conditions used, occurs through the transcriptional
control of the activator gene actII-ORF4. Similar results
have been obtained for the regulation of undecylprodi-
giosin in the same strain (Takano et al., 1992), where the
expression of the pathway-specific activator gene, redO,
is also transcriptionally regulated, and shows a strong
growth-phase dependence. How the transcriptional con-
trol of activator genes such as redO and actII-ORF4
occurs must now be addressed, and it is reasonable to
assume that at least some of the previously recognized
pleiotropic genes playa direct role in their activation.
Experimental procedures
Bacterial strains and plasm ids
Escherichia coli strains were JM101 (Sambrook et al., 1989)
and ET12567 (F-, dam-13::Tn9, dcm-6, hsdM, hsdR, zjj-
202::Tn10, recF143, galK2, ga1T22, ara-14, lacY1, xyl-5,
leuB6, thi-1, tonA31, rpsL136, hisG4, tsx-78, mt/-1, glnV44; a
gift from Tanya MacNeil). S. coelicolor A3(2) strains were
M145 (SCP1-, SCP2-, prototrophic; Hopwood et al., 1985),
J1501 (hisA1, uraA1, strA1, pgl, SCP1-, SCP2-; Hopwood et
al., 1985), and its derivatives, J1700 (bldA39; Leskiw et al.,
1991b; Lawlor et al., 1987) and J1681 (ΔbldA; B. K. Leskiw,
personal communication). E. coli plasmid pIJ452 (pUC18
(Yanisch-Perron et al., 1985) containing the 1.4 kb
BamHI-KpnI ermE coding region (Bibb et al., 1985)) was used
as a source of ermE for the construction of the translational
fusions, and pIJ5104 (Hallam et al., 1988) and pIJ2334 (a
pBR329 derivative carrying act DNA between sites 10 and 13
of the restriction map of Malpartida and Hopwood (1986)) were
used as sources of probes for S1 nuclease mapping of actIII
and actII-ORF4, respectively. Streptomyces plasmids pIJ2303
(Malpartida and Hopwood, 1986) and pIJ580 (Lawlor, 1987)
were used as templates for the polymerase chain reaction
(PCR) amplification (Erlich, 1989) of parts of actVI-ORF1 and
bldA, respectively; pIJ68 (Passantino et al., 1991) is a deriva-
tive of the multicopy vector pIJ699 (Kieser and Melton, 1988)
containing actII-ORF4, pIJ486 (Ward et al., 1986) was used as
vector for the actII-ORF4::ermE fusions, and pIJ427 is pIJ486
containing ermE as a 1.7 kb KpnI fragment (Bibb et al., 1985),
with ermE transcribed in the same direction as the neo gene of
the vector.
Culture conditions and microbiological procedures
Liquid cultures of S. coelicolor A3(2) were grown in a minimal
medium supplemented with 0.2% w/v casamino acids (Takano
et al., 1992), and actinorhodin was detected as described by
Strauch et al. (1991); protoplast production and transformation
were as in Hopwood et al. (1985). E. coli strains were grown
and transformed by standard procedures (Sambrook et al.,
1989).
Manipulation of DNA, RNA and cloning procedures
Standard procedures were used for S. coelicolor A3(2) (Hop-
wood et al., 1985) and for E. coli (Sambrook et al., 1989).
Construction of the actII-ORF4::ermE translational
fusions
The PCR was used for mutagenesis of the sequence contain-
ing the actII-ORF4 promoter and 5' coding region. The 5
oligonucleotide was 5'-AAGCTTGGATCCTCGCTGCACT-
GATTAATT-3' with a BamHI site located at positions 7-12. The
sequences of the 3' oligonucleotides were complementary to
those shown in Fig. 4; all contained a BamHI site that allowed
the PCR products to be cloned into BamHI-cleaved pIJ452
such that the N-terminal coding region of actII-ORF4 was in
frame with the full-length ermE gene present in the vector.
JM101 transform ants were selected on Luria-Bertani (LB)
plates containing ampicillin (100 µg ml-1) and then replica-
plated onto LB plates containing ampicillin (100 µg ml-1) and
lincomycin (300µg ml-1) to obtain those with the actII-ORF4
segment in the correct orientation (previous work had indicated
that protein fusions could be made to the N-terminus of the
methylase that resulted in an enzyme that could still confer
resistance to lincomycin; M. J. Bibb, unpublished). XbaI-SstI
fragments containing the actII-ORF4::ermE fusions were gel-
purified and cloned into the Streptomyces multicopy vector
pIJ486 cleaved with the same enzymes; S. coelicolor M145
transformants were selected onthiostrepton (200µg ml-1) and
then replica-plated to lincomycin (500 µg ml-1). The predicted
sequences of the final constructions were confirmed using the
dideoxy-chain termination method (Sanger et al., 1977)
adapted for use with plasmid DNA (G. Murphy, personal com-
munication) and the modified T7 DNA polymerase (Seque-
nase, USB) using oligonucletide primers synthesized on a
Pharmacia Gene Assembler.
S1 nuclease mapping
For each S1 nuclease reaction, 10-30 µg of RNA were
hybridized in NaTCA buffer (Murray, 1986) to about 0.02 pmol
(approximately 104 Cerenkov counts min-1) of the following
probes. For actII-ORF4 (Fernandez-Moreno et al., 1991), a
465 bp XhoI-AseI fragment containing the actII-ORF4 pro-
moter region uniquely labelled at the 5' end of the XhoI site
within the actII-ORF4 coding region was used. For actIII (Hal-
lam et al., 1988), a 360 bp SalI-BamHI fragment was used that
contained the actIII promoter region uniquely labelled at the 5
end of the Sail site within the actIII coding region. For bldA, the
5' end of the synthetic oligonucleotide 5'-CGGAGCCG-
GACTTGAACC-3', corresponding to a region close to the end
of the bldA gene (Lawlor et al., 1987), was labelled with [32p]_
ATP using T4 polynucleotide kinase, and then used in the PCR
with the unlabelled 5' oligonucleotide 5'-CATGGATCCACC-
CGGTAACTGATGCACC-3' that corresponds to the region
upstream of the bldA promoter to generate a 206 bp probe. For
acNI-ORF1 (F. Malpartida, personal communication), the 5'-
labelled 3' oligonucleotide 5'-ACGTCCGGCTCGTACTC-
GATG-3' and the unlabelled 5' oligonucleotide 5'-CTTGCG-
GTGGAAGTCCTCCAG-3' (whose sequence lies an un-
determined distance upstream of the actVI-ORF1 promoter)
were used in a similar fashion to generate a 471 bp probe. For
the actII-ORF4::ermE transcripts, the 5' end of the labelled
oligonucleotide 5'-GAGTTCCCTGGTGAGCAGCCCTTC-3'
(corresponding to a region approximately 250 bp downstream
of the ermE GTG start codon; Bibb et al., 1985), was used in
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the PCR with the unlabelled oligonucleotide 5'-AAGCT-
TGGATCCTCGCTGCACTGATTATT-3' (corresponding to
sequences upstream of the actII-ORF4 promoter) and pIJ2250
template DNA to generate a 403 bp probe. All subsequent
steps were as described by Strauch et al. (1991). For quantita-
tive estimates of the relative amounts of the RNA-protected
fragments, X-ray films were preflashed, exposed at -70DC
(Laskey, 1980) and scanned on a Joyce-Loebl Chromoscan 3
scanning densitometer. Increasing the amount of RNA in step-
wise fashion from 5 µg to 50 µg led to a proportional increase in
the level of protected fragment, indicating conditions of probe
excess for all of the S1 mapping experiments reported.
Protein extraction and Western blotting
Cell extracts were prepared as previously described (Gramajo
et al., 1991) and protein concentrations were determined by
the method of Bradford (1976); fractions were analysed by
SDS-PAGE (Laemmli, 1970) and by Western blotting (Burn-
ette, 1991). Antibodies against the N-terminus of the ermE
methylase were raised in rabbits using the synthetic oligopep-
tide MSSSDEQPRPRRR (Bibb et al., 1985). The antibodies
were used at 1:4000 dilution with a goat anti-rabbit IgG-alkaline
phosphatase conjugate (Bethesda Research Laboratories) as
second antibody. Relative amounts of fusion protein were
determined by scanning negatives of developed blots on a
Joyce-Loebl Chromoscan 3 scanning densitometer; varying
the amount of cell extract loaded onto the gel confirmed that
the amounts of fusion protein quantified fell within the linear
range of the negative and densitometer.
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